Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
valsartan, Quantity: 80 mg; hydrochlorothiazide, Quantity: 12.5 mg
Arrotex Pharmaceuticals Pty Ltd
Hydrochlorothiazide,Valsartan
Tablet
Excipient Ingredients: hyprolose; powdered cellulose; silicon dioxide; croscarmellose sodium; calcium hydrogen phosphate; magnesium stearate; hypromellose; titanium dioxide; iron oxide red; iron oxide yellow
Oral
28
(S4) Prescription Only Medicine
Valsartan HCTZ is indicated for the treatment of hypertension. Treatment should not be initiated with these combinations.
Visual Identification: Orange, modified, capsule shaped, film-coated tablets, engraved 'APO' on one side and '80/12.5' on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2016-03-29